Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
$4.38M
Dr. Joseph Edward Tucker Ph.D.
23.00
Naples, FL
Jun 19, 2015
-0.14
$-3.49
5.43
7.37
-1,637.24%
-0.36
0.00
0.71
6.95
7.37
-175.07%
-234.16%
Similar stocks (5)
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (5)
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%